Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Genomic landscape of ERBB2/3 alterations in colorectal cancer: Comutations, immuno-oncology biomarkers, and consensus molecular subtype.
Authors
Jeanne Tie
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
Jeanne Tie , Sherif Mohamed El-Refai , Takayuki Yoshino , Salvatore Siena , Sara Lonardi , Andrea Sartore-Bianchi , Yoshiaki Nakamura , Hideaki Bando , Takao Fujisawa , Sheau Wen Lok , Hui-Li Wong , Kunal C. Kadakia , Elizabeth Mauer , Mohamed E. Salem
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
DOI
10.1200/JCO.2022.40.4_suppl.176
Abstract #
176
Poster Bd #
J3
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Comparative molecular analyses of BRAF-V600E mutant tumors: Colorectal cancers (CRC) vs. melanomas.
First Author: Shelly Ann Christiansen
Poster
2022 ASCO Annual Meeting
Comparative analysis of microsatellite instability-high (MSI-H) BRAF V600E-mutated versus MSI-H BRAF wild type colorectal cancers (CRC), including tumor microenvironment (TME), associated genomic alterations, and immunometabolomic biomarkers.
First Author: Mohamed E. Salem
Poster
2020 ASCO Virtual Scientific Program
The landscape of MAP3K1/MAP2K4 alterations in gastrointestinal (GI) malignancies.
First Author: Matthew K Stein
Poster
2019 Gastrointestinal Cancers Symposium
Molecular comparison of primary colorectal cancer (pCRC) with peritoneal metastases (PM).
First Author: Matthew K Stein